SCHEMBL193367

SCHEMBL193367

C[S+]([O-])CCO

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31058216 1.00
SCHEMBL15947805 1.00
Dimethyl Sulfoxide SCHEMBL2440847 0.97
Hydrochloric Acid SCHEMBL31058290 0.97
Tetramethylammonium Ion SCHEMBL10924412 0.88
Ether SCHEMBL3996642 0.84 ALDH1A1 (0.42)
SCHEMBL443321 0.80
SCHEMBL22813655 0.80
SCHEMBL6033422 0.78
Dimethyl Sulfoxide SCHEMBL4214897 0.78 ALDH1A1 (0.33)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 338 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023191400-A1 ETHYL PIPERIDINE TRIAZOLO TRIAZINE DERIVATIVES, SYNTHESIS METHOD THEREFOR, AND PHARMACEUTICAL COMPOSITION CONTAINING SAME FOR PREVENTION OR TREATMENT OF CANCER 에이치케이이노엔 주식회사 2023-10-05 WO claimed
CN-108627576-A The quantitative analysis method of Tadalafei in a kind of human plasma 武汉宏韧生物医药科技有限公司 2018-10-09 CN claimed
EP-2055703-B1 NOVEL PYRIMIDINE COMPOUND HAVING BENZYL(PYRIDYLMETHYL)AMINE STRUCTURE AND PHARMACEUTICAL COMPRISING THE COMPOUND KOWA CO (JP) 2012-05-30 EP claimed
US-7750019-B2 Pyrimidine compound having benzyl(pyridylmethyl)amine structure and medicament comprising the same KOWA COMPANY, LTD. (JP) 2010-07-06 US claimed
EP-2055703-A1 NOVEL PYRIMIDINE COMPOUND HAVING BENZYL(PYRIDYLMETHYL)AMINE STRUCTURE AND PHARMACEUTICAL COMPRISING THE COMPOUND Kowa Company. Ltd. (JP) 2009-05-06 EP claimed
US-20090054474-A1 Novel pyrimidine compound having benzyl(pyridylmethyl)amine structure and medicament comprising the same KOWA COMPANY, LTD. (JP) 2009-02-26 US claimed
EP-0096007-B1 PHARMACEUTICAL PREPARATIONS CONTAINING (+)-CYANIDAN-3-OL DERIVATIVES, THE USE THEREOF, NOVEL SUBSTITUTED (+)-CYANIDAN-3-OL DERIVATIVES, AND PROCESSES FOR PRODUCING THEM Zyma SA (CH) 1987-07-29 EP claimed
EP-0096007-A2 Pharmaceutical preparations containing (+)-cyanidan-3-ol derivatives, the use thereof, novel substituted (+)-cyanidan-3-ol derivatives, and processes for producing them Zyma SA (CH) 1983-12-07 EP claimed
EP-0024290-B1 8-PHENYL PURINES, THEIR PREPARATION AND MEDICAMENTS CONTAINING THEM Dr. Karl Thomae GmbH (DE) 1982-12-22 EP claimed
US-4342769-A 2-[(Methylsulfinyl)acetyl]-3-heterocyclicindoles and derivatives thereof as immunosuppressants SCHERING CORPORATION (US) 1982-08-03 US claimed
US-4328345-A Pyridyl substituted indoles SCHERING CORPORATION (US) 1982-05-04 US claimed
US-4299834-A INOTROPIC ACTIVITY BOEHRINGER INGELHEIM GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) 1981-11-10 US claimed
US-4255442-A 2-[(Methylsulfinyl)]-3-phenylindoles SCHERING CORPORATION (US) 1981-03-10 US claimed
US-4225711-A Substituted 2-[(methylsulfinyl)acetyl]-3-heterocyclicindoles and their use as immunosuppressants SCHERING CORPORATION (US) 1980-09-30 US claimed
US-3985891-A CARDIOTONICS, ANTICOAGULANTS BOEHRINGER INGELHEIM GMBH (DT) 1976-10-12 US claimed
US-20240234798-A1 METHOD FOR PRODUCING SOLID ELECTROLYTE PARTICLES AND METHOD FOR PRODUCING ALL-SOLID-STATE BATTERY MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) 2024-07-11 US disclosed
US-20240194936-A1 METHOD FOR PRODUCING SOLID ELECTROLYTE POWDER, AND METHOD FOR PRODUCING ALL SOLID STATE BATTERY MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) 2024-06-13 US disclosed
US-4109082-A PROSTACYCLIN ANALOGS; SMOOTH MUSCLE STIMULATORS THE UPJOHN COMPANY (US) 1978-08-22 US disclosed
US-3985891-A CARDIOTONICS, ANTICOAGULANTS BOEHRINGER INGELHEIM GMBH (DT) 1976-10-12 US disclosed
US-3985891-A CARDIOTONICS, ANTICOAGULANTS BOEHRINGER INGELHEIM GMBH (DT) 1976-10-12 US disclosed